Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04979728 · ClinicalTrials.gov registry record

HIV Outpatient Monitoring Evaluation Through Self-collection of Dried Blood Spots

A clinical trial of HIV Prevention and HIV Treatment, sponsored by University of Colorado, Denver.

Recruiting
Registry status
150
Enrollment target
1
Study location

NCT04979728 is a study of HIV Prevention and HIV Treatment that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 150 participants, below the 377-participant average among 32 other HIV Prevention trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04979728, a study of HIV Prevention and HIV Treatment, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
150 participants
Enrollment target
1
Study location

Study Summary

The goal of this observational study is to establish an operational framework for home self-collections of blood samples to be used for antiviral drug concentration measurements. Participants will continue on their prescribed antiviral(s) for HIV treatment or prevention and followed for up to approximately 1 year. The investigators will compare drug concentrations of antivirals and relevant metabolites/anabolites in clinic-collected and self-collected blood samples.

Interventions

  • OTHER At Home Self-Collections

Study Locations (1)

Colorado

  • University of Colorado Hospital (UCHealth) - Aurora

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2021-05-27
Est. Completion 2027-06-30

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT04979728

The ClinicalTrials.gov registry entry for NCT04979728 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 377-participant average among 32 other HIV Prevention trials with a reported enrollment target (60% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with HIV Prevention appearing as the primary indexed condition, and to 1 intervention - of which At Home Self-Collections is the first listed.

NCT04979728 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT04979728 about?

NCT04979728 is a clinical study titled "HIV Outpatient Monitoring Evaluation Through Self-collection of Dried Blood Spots". The goal of this observational study is to establish an operational framework for home self-collections of blood samples to be used for antiviral drug concentration measurements. Participants will continue on their prescribed antiviral(s) for HIV treatment or prevention and followed for up to appro...

What is the current status of trial NCT04979728?

This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2021-05-27. Estimated completion is 2027-06-30.

What conditions does trial NCT04979728 study?

This clinical trial studies the following conditions: HIV Prevention, HIV Treatment.

What interventions are being tested in trial NCT04979728?

The interventions under investigation include: At Home Self-Collections (OTHER).

Who is sponsoring clinical trial NCT04979728?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04979728 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Prevention

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.